MARC details
| 000 -LEADER |
|---|
| fixed length control field |
06809cam a2200829 i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
ocn870331213 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20221128212754.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION |
|---|
| fixed length control field |
m d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr un||||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
140516s2014 dcua obt 100 0 eng |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2014451576 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
NLM |
| 016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER |
|---|
| Record control number |
101633144 |
| Source |
DNLM |
| 019 ## - |
|---|
| -- |
871260167 |
| -- |
923287859 |
| -- |
971083063 |
| -- |
1021272863 |
| -- |
1061003944 |
| -- |
1061062305 |
| -- |
1077380361 |
| -- |
1081271153 |
| -- |
1156332799 |
| -- |
1228550393 |
| -- |
1249253375 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| ISBN |
9780309285964 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| ISBN |
0309285968 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| ISBN |
9780309285971 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| ISBN |
0309285976 |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
867773 |
| -- |
(N$T) |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(OCoLC)870331213 |
| Canceled/invalid control number |
(OCoLC)871260167 |
| -- |
(OCoLC)923287859 |
| -- |
(OCoLC)971083063 |
| -- |
(OCoLC)1021272863 |
| -- |
(OCoLC)1061003944 |
| -- |
(OCoLC)1061062305 |
| -- |
(OCoLC)1077380361 |
| -- |
(OCoLC)1081271153 |
| -- |
(OCoLC)1156332799 |
| -- |
(OCoLC)1228550393 |
| -- |
(OCoLC)1249253375 |
| 042 ## - AUTHENTICATION CODE |
|---|
| Authentication code |
pcc |
| 043 ## - GEOGRAPHIC AREA CODE |
|---|
| Geographic area code |
a-cc--- |
| 060 00 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
2014 I-005 |
| 060 00 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
WF 200 |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
POL |
| Subject category code subdivision |
027000 |
| Source |
bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
POL |
| Subject category code subdivision |
019000 |
| Source |
bisacsh |
| 049 ## - LOCAL HOLDINGS (OCLC) |
|---|
| Holding library |
MAIN |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal author |
Olson, Steve, |
| Relator term |
author. |
| 245 14 - TITLE STATEMENT |
|---|
| Title |
The global crisis of drug-resistant tuberculosis and leadership of China and the BRICS : |
| Subtitle |
challenges and opportunities : summary of a joint workshop by the Institute of Medicine and the Institute of Microbiology, Chinese Academy of Sciences |
| Statement of responsibility, etc |
|
| Medium |
[E-Book] |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
Washington, D.C. : |
| Name of producer, publisher, distributor, manufacturer |
The National Academies Press, |
| Date of production, publication, distribution, manufacture, or copyright notice |
[2014] |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Physical description |
1 online resource (1 PDF file (xxi, 195 pages)) : |
| Other physical details |
illustrations |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
computer |
| Media type code |
c |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
online resource |
| Carrier type code |
cr |
| Source |
rdacarrier |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Title from PDF title page. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references. |
| 520 3# - ABSTRACT |
|---|
| Abstract |
Multidrug-resistant tuberculosis (TB) is caused by bacteria resistant to isoniazid and rifampicin, the two most effective first-line anti-TB drugs, originally developed and introduced in the 1950 and 1960s. Since 2008, the Forum on Drug Discovery, Development, and Translation of the Institute of Medicine has hosted or co-hosted six domestic and international workshops addressing the global crisis of drug-resistant TB, with special attention to the BRICS countries - Brazil, Russia, India, China, and South Africa. The Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS is the summary of a workshop convened to address the current status of drug-resistant TB globally and in China. This report considers lessons learned from high burden countries; highlights global challenges to controlling the spread of drug-resistant strains; and discusses innovative strategies to advance and harmonize local and international efforts to prevent and treat drug-resistant TB. Additionally, the report examines the problem of MDR TB and emergent TB strains that are potentially untreatable with drugs available and considers the critical leadership role of the BRICS countries in addressing the threats and opportunities in drug-resistant TB. |
| 505 0# - CONTENTS |
|---|
| Contents |
The challenges and opportunities for the BRICS countries to lead -- Catching up with the microbe -- Drug-resistant TB in China -- Experiences with MDR TB in other countries -- Drug-resistant tuberculosis in pediatric populations -- Global perspectives on transmission and infection control -- Rapid diagnostic technologies : status and limitations -- Addressing diagnosis and treatment across the spectrum of drug resistance -- Developing and strengthening the drug supply chain for drug-resistant TB -- Embracing a new vision for research -- What will be required to achive zero deaths from TB? -- Creating an evidence-based blueprint for action. |
| 590 ## - LOCAL NOTE (RLIN) |
|---|
| Local note |
WorldCat record variable field(s) change: 650 |
| 650 #0 - SUBJECT HEADINGS |
|---|
| Subject term |
Multidrug-resistant tuberculosis |
| 650 #0 - SUBJECT HEADINGS |
|---|
| Subject term |
Multidrug-resistant tuberculosis |
| General subdivision |
Prevention |
| 650 #0 - SUBJECT HEADINGS |
|---|
| Subject term |
Tuberculosis |
| 650 #0 - SUBJECT HEADINGS |
|---|
| Subject term |
Drug resistance |
| 650 #0 - SUBJECT HEADINGS |
|---|
| Subject term |
Multidrug-resistant tuberculosis. |
| 650 #0 - SUBJECT HEADINGS |
|---|
| Subject term |
Antitubercular agents. |
| 9 (RLIN) |
5248 |
| 650 #0 - SUBJECT HEADINGS |
|---|
| Subject term |
World health. |
| 650 #0 - SUBJECT HEADINGS |
|---|
| Subject term |
International cooperation. |
| 650 12 - SUBJECT HEADINGS |
|---|
| Subject term |
Tuberculosis, Multidrug-Resistant |
| 650 22 - SUBJECT HEADINGS |
|---|
| Subject term |
Antitubercular Agents |
| 9 (RLIN) |
5248 |
| 650 22 - SUBJECT HEADINGS |
|---|
| Subject term |
Global Health |
| 650 22 - SUBJECT HEADINGS |
|---|
| Subject term |
International Cooperation |
| 700 1# - ADDED PERSONAL NAME |
|---|
| Added personal author |
English, Rebecca A., |
| Relator term |
author. |
| 700 1# - ADDED PERSONAL NAME |
|---|
| Added personal author |
Claiborne, Anne B., |
| Relator term |
author. |
| 710 2# - ADDED CORPORATE NAME |
|---|
| Added corporate author |
Institute of Medicine (U.S.). |
| Subordinate unit |
Forum on Drug Discovery, Development, and Translation, |
| Relator term |
issuing body. |
| 710 2# - ADDED CORPORATE NAME |
|---|
| Added corporate author |
Institute of Medicine (U.S.), |
| Relator term |
sponsoring body. |
| 710 2# - ADDED CORPORATE NAME |
|---|
| Added corporate author |
Zhongguo ke xue yuan. |
| Subordinate unit |
Wei sheng wu yan jiu suo, |
| Relator term |
sponsoring body. |
| 711 2# - ADDED ENTRY--MEETING NAME |
|---|
| Meeting name or jurisdiction name as entry element |
Global Crisis of Drug-Resistant Tuberculosis and Leadership of the BRICS Countries : Challenges and Opportunities (Workshop) |
| 856 40 - ONLINE RESOURCE |
|---|
| Uniform Resource Identifier |
<a href="https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=867773">https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=867773</a> |
| Link text |
Kingston Hospital NHS Foundation Trust OpenAthens account holders click here for access |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Suppress in OPAC |
Do not Suppress in OPAC |
| 536 ## - FUNDING INFORMATION NOTE |
|---|
| Text of note |
This activity was supported by contracts between the National Academy of Sciences and Department of Health and Human Services (HHSN26300023 [Under Base #HHSN263201200074I] and Contract No. N01-OD-4-2139 TO #276; HHSF22301026T [Under Base #HHSF223200810020I]), AbbVie Inc., American Diabetes Association, American Society for Microbiology, Amgen Inc., Association of American Medical Colleges, AstraZeneca, Bristol-Myers Squibb, Burroughs Wellcome Fund, CDC Foundation, Celtic Therapeutics, LLLP, Critical Path Institute, Doris Duke Charitable Foundation, Eli Lilly & Co. Foundation, Eli Lilly and Company, FasterCures, Fondation Merieux, Friends of Cancer Research, GlaxoSmithKline, Johnson & Johnson, March of Dimes Foundation, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Pfizer Inc., and Sanofi. The views presented in this publication do not necessarily reflect the views of the organizations or agencies that provided support for the activity. |
| 588 0# - SOURCE OF DESCRIPTION NOTE |
|---|
| Source of description note |
Version viewed June 30, 2014. |
| 651 #2 - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME |
|---|
| Geographic name |
China |
| 938 ## - |
|---|
| -- |
Askews and Holts Library Services |
| -- |
ASKH |
| -- |
AH36561400 |
| 938 ## - |
|---|
| -- |
Askews and Holts Library Services |
| -- |
ASKH |
| -- |
AH36617758 |
| 938 ## - |
|---|
| -- |
ProQuest Ebook Central |
| -- |
EBLB |
| -- |
EBL3379093 |
| 938 ## - |
|---|
| -- |
ebrary |
| -- |
EBRY |
| -- |
ebr10863741 |
| 938 ## - |
|---|
| -- |
EBSCOhost |
| -- |
EBSC |
| -- |
867773 |
| 938 ## - |
|---|
| -- |
YBP Library Services |
| -- |
YANK |
| -- |
11575900 |
| 938 ## - |
|---|
| -- |
YBP Library Services |
| -- |
YANK |
| -- |
11864833 |
| 994 ## - |
|---|
| -- |
92 |
| -- |
N$T |